https://sputniknews.in/20260804/russias-personalised-cancer-vaccine-passes-first-milestone-as-melanoma-patient-nears-full-course-11861391.html
Russia's Personalised Cancer Vaccine Passes First Milestone As Melanoma Patient Nears Full Course
Russia's Personalised Cancer Vaccine Passes First Milestone As Melanoma Patient Nears Full Course
Sputnik India
The patient is a 60-year-old resident of Russia’s Kursk region who received the first dose of the "Neoonkovak" vaccine in April. 04.08.2026, Sputnik India
2026-08-04T13:21+0530
2026-08-04T13:21+0530
2026-08-04T13:46+0530
russia
health
science & tech
russia
https://cdn1.img.sputniknews.in/img/07e8/0c/01/8476549_0:106:2021:1242_1920x0_80_0_0_cfaef263abf7530f89c52af2ab4df358.jpg
The man with melanoma that had spread to lymph nodes despite prior surgeries will receive the final dose of the vaccine in early September, Alexander Gintsburg, director of the Gamaleya Research Institute of Epidemiology and Microbiology, tells Sputnik.Russia’s Ministry of Health authorized clinical use of the mRNA oncovaccine in December.Production is handled by the National Medical Research Radiological Center.Twenty patients will receive Russia's first skin cancer vaccine by the end of 2026, Alexander Gintsburg confirmed in July.
https://sputniknews.in/20260414/russian-scientists-make-incredible-breakthrough-against-cancer-10752725.html
russia
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2026
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_IN
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
health, science & tech, russia
health, science & tech, russia
Russia's Personalised Cancer Vaccine Passes First Milestone As Melanoma Patient Nears Full Course
13:21 04.08.2026 (Updated: 13:46 04.08.2026) The patient is a 60-year-old resident of Russia’s Kursk region who received the first dose of the "Neoonkovak" vaccine in April.
The man with melanoma that had spread to lymph nodes despite prior surgeries will receive the final dose of the vaccine in early September, Alexander Gintsburg, director of the Gamaleya Research Institute of Epidemiology and Microbiology, tells Sputnik.
Russia’s Ministry of Health authorized clinical use of the mRNA oncovaccine in December.
Production is handled by the National Medical Research Radiological Center.
The cancer vaccine is created individually for each patient based on the molecular and genetic characteristics of their tumor.
Twenty patients will receive Russia's first skin cancer vaccine by the end of 2026, Alexander Gintsburg confirmed in July.
